Professor Dr Chan Wah Kheong

MRCP (UK), MBBS (UM), Ph.D (Malaya)(A.M)

 

Clinic Schedule and Appointment List

  • Mon 19/10
    Not Available
  • Tue 20/10
    Not Available
  • Wed 21/10
    Not Available
  • Thu 22/10
    Not Available
  • Fri 23/10
    09:00 - 11:45
  • Sat 24/10
    Not Available

 

Enquiry and Contact Details

 

 

The Doctor

Specialises in

 

 

Research and

Publications

  • 2020 Predictors of advanced fibrosis in elderly patients with biopsy-confirmed nonalcoholic fatty liver disease: the GOASIA study
  • 2020 Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement
  • 2020 Noninvasive Tests in the Assessment of NASH and NAFLD Fibrosis: Now and Into the Future
  • 2020 increasing burden of nonalcoholic fatty liver disease—a call to action
  • 2020 Positive Hepatitis B Core Antibody Is Associated With Cirrhosis and Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
  • 2020 Epidemiological differences of common liver conditions between Asia and the West
  • 2020 Gamma-glutamyl transferase and cardiovascular risk in nonalcoholic fatty liver disease: The Gut and Obesity Asia initiative
  • 2020 HLA-DQB1* 06 reduces fibrosis score in patients with non-alcoholic fatty liver disease.
  • 2020 329 THE IMPACT OF FATIGUE ON PATIENT-REPORTED OUTCOMES (PRO) IN PATIENTS WITH CHRONIC LIVER DISEASE (CLD): DATA FROM THE GLOBAL LIVER REGISTRY (GLR)
  • 2020 A new definition for metabolic associated fatty liver disease: an international expert consensus statement
  • 2020 Development and validation of a novel non‐invasive test for diagnosing fibrotic non‐alcoholic steatohepatitis in patients with biopsy‐proven non‐alcoholic fatty liver disease
  • 2020 Volumetric Liver Fat Fraction Determines Grade of Steatosis More Accurately Than Controlled Attenuation Parameter in Patients With Nonalcoholic Fatty Liver Disease
  • 2020 Epidemiology of non-alcoholic fatty liver disease in Asia
  • 2020 FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study
  • 2020 Suboptimal treatment of dyslipidemia in patients with nonalcoholic fatty liver disease
  • 2020 Empagliflozin for the treatment of nonalcoholic steatohepatitis in patients with type 2 diabetes mellitus
  • 2020 Liver stiffness measurement in non‐alcoholic fatty liver disease: Two is better than one
  • 2020 Comparing point shear wave elastography (ElastPQ) and transient elastography for diagnosis of fibrosis stage in non‐alcoholic fatty liver disease
  • 2020 Adams, L.A., and Chan, W.K. (2020). Noninvasive Tests in the Assessment of NASH and NAFLD Fibrosis: Now and Into the Future. Semin Liv Dis. Doi: 10.1055/s-0040-1713006. (ISI-Indexed)
  • 2020 Tan, E. Z-Y., Lai, L.L., Vethakkan, S. R., Nik Mustapha, N. R., Mahadeva, S., Chan, W-K . (in press). Modest alcohol intake is not associated with significant hepatic steatosis nor more severe liver disease in patient with diabetes mellitus. J Gastroen Hepatol. (ISI-Indexed)
  • 2020 Wong, G. L-H., Vincent Wong, W-S., Thompson, A., Jia, J., Hou, J., Lesmana, C.R.A., et al. (2020). Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement. Lancet Gastroenterol Hepatol. Doi.org/10.1016/S2468-1253(20)30190-4. (ISI-Indexed)
  • 2020 Chong CCN, Lakhtakia S, Nguyen N, et al. Endoscopic ultrasound-guided tissue acquisition with or without macroscopic on-site evaluation: randomized controlled trial [published online ahead of print, 2020 Jun 4]. Endoscopy. 2020;10.1055/a-1172-6027. doi:10.1055/a-1172-6027 (ISI-Indexed)
  • 2020 Pitisuttithum, P., Chan, W. K., Piyachaturawat, P., Imajo, K., Nakajima, A., Seki, Y et al. (2020). Predictors of advanced fibrosis in elderly patients with biopsy-confirmed nonalcoholic fatty liver disease: the GOASIA study. BMC Gastroenterol. Doi: 10.1186/s12876-020-01240-z. (ISI-Indexed)
  • 2020 Gao, F., Huang, J. F., Zheng, K. I., Pan, X. Y., Ma, H. L., Liu, W. Y et al. (2020). Development and validation of a novel non-invasive test for diagnosing fibrotic NASH in patients with biopsy-proven NAFLD. J Gastroenterol Hepatol. https://doi.org/10.1111/jgh.15055. (ISI-Indexed)
  • 2020 Eslam, M., Newsome, P. N., Anstee, Q. M., Targher, G., Gomez, M. R., Zelber-Segi, S et al. (2020). A new definition for metabolic associated fatty liver disease :an international expert consensus statement. Journal of Hepatology. https://doi.org/10.1016/j.jhep.2020.03.039. (ISI-Indexed)
  • 2020 Chan, T. T., Chan, W. K., Wong, G. L., Chan, A. W., Nik Mustapha, N. R., Chan, S. L (2020). Positive Hepatitis B core antibody is associated with cirrhosis and hepatocellular carcinoma in nonalcoholic fatty liver disease. Am J Gastroenterol. Doi: 10.14309/ajg.00(13)588. (ISI-Indexed)
  • 2020 Newsome, P. N., Sasso, M., Deeks, J.J., Paredes, A., Boursier, J., Chan, W-K et al. (2020). FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study. Lancet Gastroenterol Hepatol. https://doi.org/10.1016/S2468-1253(19)30383-8 (ISI-Indexed)
  • 2020 Wong, S.W and Chan, W.K (2020). Epidemiology of non-alcoholic fatty liver disease in Asia Indian Journal of Gastroenterology. Indian Journal of Gastroenterology. (ISI-Indexed)

 

Fellowships, Memberships &

Professional Affiliations

  • Professor of Medicine, University of Malaya
  • Senior Consultant Gastroenterologist and Hepatologist, University of Malaya Medical Centre
  • Senior Consultant Gastroenterologist and Hepatologist, University of Malaya Specialist Centre
  • Associate Editor, Journal of Gastroenterology and Hepatology
  • Committee Member, Malaysian Society of Gastroenterology and Hepatology
  • Scientific Co-Chair, Asia Pacific Digestive Week 2021
  • Visiting Scholar in Endoscopy, Kyushu University Hospital, Kyushu, Japan, 2011
  • Asian Young Endoscopist Award 2015, Korean Society of Gastrointestinal Endoscopy
  • Fellow in Endoscopic Retrograde Cholangiopancreatography, Soonchunhyang University Bucheon Hospital, Bucheon, Korea, 2015
  • Fellow in Endoscopic Ultrasonography, Asian Institute of Gastroenterology, Hyderabad, India, 2015
  • Clinical Research Fellow in Hepatology, Storr Liver Centre, Sydney, Australia, 2019
  • Member, Asia Pacific Working Party on Nonalcoholic Fatty Liver Disease
  • Member, Gut and Obesity in Asia Workgroup
  • Member, Global NASH Council
  • Member, American Association for the Study of Liver Disease

 

Awards and

Recognitions

  • Best Paper Award 1st Prize at the Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2012, Malaysian Society of Gastroenterology and Hepatology, 2012
 
  • Best Paper Award 1st Prize at the Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2013 , Malaysian Society of Gastroenterology and Hepatology, 2013
 
  • Poster of Distinction: Controlled attenuation parameter for the detection and quantification of hepatic steatosis in non-alcoholic fatty liver disease,at the 23rd Conference of the Asian Pacific Association in the Study of the Liver 2014, Asian Pacific Association in the Study of the Liver 2014, 2014
 
  • Scholarship as Visiting Scholar to Kyushu University Hospital, Kyushu University Hospital, 2011